RxDoctor Payments Data

Scott Dunn, MD

Family Medicine · Sandpoint, IDNPI 1952308405

Payments from drug & device makers

$586in general payments, 2019–2025

Across 24 payments — averaging $24.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$187
  • Exact Sciences$62
  • Lilly USA, LLC$49
  • Sanofi Pasteur Inc.$47
  • Coopersurgical, Inc.$47
  • Pfizer$43
  • plus $152 from 8 others

What the payments were for

  • Food & beverage$586100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$586 in reported general payments places this provider in the 65th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$156,351
Medicare patients
504
Services billed
1,837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban193$181,020
OzempicSemaglutide112$132,877
JardianceEmpagliflozin83$81,941
XareltoRivaroxaban60$61,551
Invega SustennaPaliperidone Palmitate11$35,815
RybelsusSemaglutide26$34,399
MounjaroTirzepatide19$30,009
TrulicityDulaglutide28$28,938
Victoza 3-PakLiraglutide17$18,476
Spiriva RespimatTiotropium Bromide27$18,113
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr30$13,857
Tresiba Flextouch U-100Insulin Degludec25$13,537
Combivent RespimatIpratropium/Albuterol Sulfate22$10,282
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog28$7,164
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$5,866

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$43$181,020193 claims
Novo NordiskOzempic, Rybelsus$187$167,275138 claims
Lilly USA, LLCMounjaro, Trulicity$49$58,94747 claims
GSKAnoro Ellipta$26$13,85730 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 803 family medicine providers in Idaho.

Other family medicine in Sandpoint

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →